Gladius Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-528
Closed -$34.3K 108
2024
Q3
$34.3K Buy
528
+38
+8% +$2.44K ﹤0.01% 180
2024
Q2
$30.4K Buy
+490
New +$34K ﹤0.01% 255
2024
Q1
Sell
-450
Closed -$33.7K 337
2023
Q4
$33.7K Sell
450
-28
-6% -$1.94K 0.01% 257
2023
Q3
$33.1K Sell
478
-337
-41% -$24.1K ﹤0.01% 272
2023
Q2
$59.2K Sell
815
-392
-32% -$26.5K ﹤0.01% 188
2023
Q1
$86.8K Buy
1,207
+117
+11% +$8.96K 0.01% 192
2022
Q4
$81.3K Buy
1,090
+534
+96% +$38.3K 0.01% 184
2022
Q3
$37K Buy
+556
New +$42.6K ﹤0.01% 232

Other funds holding CRI

Gladius Capital Management's CRI Position: Q4 2024 in Review

Gladius Capital Management sold out of Carter's (CRI) in Q4 2024, closing a stake of 528 shares — an estimated $34.3K sold.

Gladius Capital Management first reported a position in CRI in Q3 2022 and held it in 8 quarters. The position peaked at $86.8K in Q1 2023. 317 funds tracked by Wall St. Rank hold CRI as of Q4 2024.

  • Gladius Capital Management reported no remaining Carter's position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 528 Carter's shares in Q4 2024, an estimated $34.3K.
  • Gladius Capital Management first reported a position in Carter's in Q3 2022 and held it in 8 quarters.
  • Gladius Capital Management's Carter's position peaked at $86.8K in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Carter's as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.